EF Hutton Reiterates Buy on Tetra Technologies, Maintains $8.5 Price Target
EF Hutton analyst Tim Moore reiterates Tetra Technologies (NYSE:TTI) with a Buy and maintains $8.5 price target.
EF Hutton Reiterates Buy on Tetra Technologies, Maintains $9 Price Target
EF Hutton analyst Tim Moore reiterates Tetra Technologies (NYSE:TTI) with a Buy and maintains $9 price target.
S&P 500 Rises 1%, InMed Pharmaceuticals Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Monday.
Tetra Technologies Q2 EPS $0.05, Inline, Sales $140.72M Beat $134.70M Estimate
Tetra Technologies (NYSE:TTI) reported quarterly earnings of $0.05 per share which met the analyst consensus estimate. This is a 350 percent increase over losses of $(0.02) per share from the same period last year. The
Earnings Scheduled For August 1, 2022
Companies Reporting Before The Bell
• Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.
Preview: Tetra Technologies’s Earnings
Tetra Technologies (NYSE:TTI) is set to give its latest quarterly earnings report on Monday, 2022-08-01. Here's what investors need to know before the announcement.
Analysts estimate that Tetra Technologies will report an earnings per share (EPS) of $0.05.
80 Biggest Movers From Yesterday
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume.
Mid-Afternoon Market Update: Kymera Therapeutics Drops After Q1 Results; Belite Bio Shares Spike Higher
U.S. stocks traded slightly higher toward the end of trading on Tuesday.
Mid-Day Market Update: Dow Jumps 100 Points; Spero Therapeutics Shares Plunge
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Tuesday.